NASDAQ:EXOZ

eXoZymes Q3 2026 Earnings Results & Report

eXoZymes logo
$3.44 -0.55 (-13.68%)
Closing price 03:55 PM Eastern
Extended Trading
$3.45 +0.00 (+0.15%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

eXoZymes reported Q3 2026 earnings on November 13, 2026. The company reported EPS of -$0.24.

Earnings Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Conference Call
5:00 PM ET

eXoZymes EPS Results

Actual EPS
-$0.24
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

eXoZymes Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

eXoZymes Q3 2026 Earnings FAQ

eXoZymes (NASDAQ:EXOZ) reported earnings of -$0.24 per share for Q3 2026. The report was announced on Friday, November 13, 2026.

eXoZymes Earnings Headlines

Reviewing eXoZymes (NASDAQ:EXOZ) and Upstream Bio (NASDAQ:UPB)
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
See More eXoZymes Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like eXoZymes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on eXoZymes and other key companies, straight to your email.

About eXoZymes

eXoZymes (NASDAQ:EXOZ) is a biotechnology company focused on cell-free biomanufacturing. Its approach uses enzymes outside living cells to produce compounds, offering an alternative to conventional manufacturing methods.

The company’s work centers on developing its biomanufacturing platform and applying it to the production of useful molecules. Publicly available information about specific commercial products, customer markets, geographic reach and company leadership is limited.

View eXoZymes Profile